首页> 外文期刊>Therapeutic delivery >Buccal drug delivery: What's new and what does the future hold?
【24h】

Buccal drug delivery: What's new and what does the future hold?

机译:口腔药物输送:有哪些新功能?未来将如何发展?

获取原文
获取原文并翻译 | 示例
           

摘要

The buccal mucosa is the stratified squamous epithelial tissue inside lining of the cheeks. It is a favorable site of drug absorption since the tissue is non-keratinized, relatively immobile and strongly supplied with blood by a dense capillary-vessel network; moreover, it is highly tolerant to allergens, resistant to potentially harmful agents and has a relatively low enzymatic activity. The tissue consents quick onset of effect, offers an easily accessible and generally well-accepted site for drug delivery, is a useful route of administration in patients in an unconscious state (e.g., when swallowing is impaired), and is suitable for retentive dosage forms of administration.
机译:颊粘膜是颊壁内的分层鳞状上皮组织。它是药物吸收的有利部位,因为组织没有角质化,相对不动,并通过致密的毛细血管网络强烈供血;此外,它对过敏原具有高度的耐受性,对潜在有害的药物具有抗性,并且具有较低的酶活性。该组织具有起效快的作用,为药物输送提供了容易接近且通常为人们所接受的部位,是处于无意识状态(例如吞咽障碍时)的患者的有用给药途径,并且适合于保持性剂型管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号